Reviva Pharmaceuticals Holdings, Inc. (RVPH) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 23.56M | 15.1M | 13.51M | 10.82M | 6.26M | 14.68M | 6.81M | 7.23M | 13.5M | 23.7M | 5.39M | 11.84M |
| Cash & Short-Term Investments | 22.19M | 14.44M | 13.18M | 10.36M | 5.29M | 13.48M | 5.56M | 6.18M | 11.97M | 23.37M | 4.97M | 11.15M |
| Cash Only | 22.19M | 14.44M | 13.18M | 10.36M | 5.29M | 13.48M | 5.56M | 6.18M | 11.97M | 23.37M | 4.97M | 11.15M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.37M | 664.68K | 247.93K | 346.96K | 756.07K | 666.43K | 0 | 525.83K | 743.38K | 254.64K | 414.74K | 690.44K |
| Total Non-Current Assets | 0 | 819.72K | 819.72K | 819.72K | 819.72K | 819.72K | 819.72K | 819.72K | 0 | 0 | 0 | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 819.72K | 819.72K | 819.72K | 819.72K | 819.72K | 819.72K | 819.72K | 0 | 0 | 0 | 0 |
| Total Assets | 23.56M | 15.92M | 14.33M | 11.63M | 7.08M | 15.5M | 7.63M | 8.05M | 13.5M | 23.7M | 5.39M | 11.84M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 232.9% | 2.71% | 87.85% | 44.48% | -47.56% | -34.59% | 41.63% | -32% | 4.61% | 25.24% | -77.59% | -42.64% |
| Total Current Liabilities | 6.12M | 7.28M | 9.74M | 12.08M | 11.51M | 14.6M | 17.53M | 13.94M | 14.49M | 17.18M | 13.03M | 9.21M |
| Accounts Payable | 2.09M | 3.01M | 5.43M | 4.97M | 4.72M | 6.28M | 8.78M | 4.69M | 5.72M | 3.85M | 5.28M | 2.65M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 231.27K | 406.88K | 0 | 113.25K | 224.3K | 458.15K | 83K | 207.5K | 332K | 0 | 222.5K | 222.5K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.8M | 485.9K | 784.96K | 602.59K | 556.88K | 635.59K | 428.8K | 445.37K | 377.37K | 958.61K | 2.25M | 3.69M |
| Current Ratio | 3.85x | 2.08x | 1.39x | 0.90x | 0.54x | 1.01x | 0.39x | 0.52x | 0.93x | 1.38x | 0.41x | 1.29x |
| Quick Ratio | 3.85x | 2.08x | 1.39x | 0.90x | 0.54x | 1.01x | 0.39x | 0.52x | 0.93x | 1.38x | 0.41x | 1.29x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 44.51K | 16.69K | 27.82K | 89.01K | 77.88K | 150.21K | 350.48K | 806.65K | 873.41K | 1.01M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 44.51K | 16.69K | 27.82K | 89.01K | 77.88K | 150.21K | 350.48K | 806.65K | 0 | 1.01M |
| Total Liabilities | 6.12M | 7.28M | 9.78M | 12.09M | 11.54M | 14.69M | 17.61M | 14.09M | 14.84M | 17.98M | 13.91M | 10.22M |
| Total Debt | 231.27K | 406.88K | 0 | 113.25K | 224.3K | 458.15K | 83K | 207.5K | 332K | 0 | 222.5K | 222.5K |
| Net Debt | -21.96M | -14.03M | -13.18M | -10.25M | -5.07M | -13.02M | -5.48M | -5.97M | -11.64M | -23.37M | -4.75M | -10.93M |
| Debt / Equity | 0.01x | 0.05x | - | - | - | 0.56x | - | - | - | - | - | 0.14x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -479.88x | - | -1537.55x | -1259.30x | -552.15x | -1326.69x | -1624.69x | -1522.88x | -2128.69x | -1350.76x | -1814.79x | -946.04x |
| Total Equity | 17.44M | 8.65M | 4.55M | -459.15K | -4.46M | 812.57K | -9.98M | -6.04M | -1.35M | 5.72M | -8.52M | 1.62M |
| Equity Growth % | 491.04% | 964.23% | 145.58% | 92.4% | -231.4% | -85.79% | -17.17% | -472.66% | -123.26% | -53.57% | -141.84% | -89.91% |
| Book Value per Share | 2.48 | 2.38 | 1.25 | -0.18 | -1.83 | 0.49 | -5.91 | -3.95 | -0.90 | 4.20 | -7.09 | 1.45 |
| Total Shareholders' Equity | 17.44M | 8.65M | 4.55M | -459.15K | -4.46M | 812.57K | -9.98M | -6.04M | -1.35M | 5.72M | -8.52M | 1.62M |
| Common Stock | 12.35K | 11.65K | 9.62K | 6.8K | 4.67K | 4.66K | 3.34K | 2.98K | 2.79K | 2.79K | 2.27K | 2.27K |
| Retained Earnings | -187.33M | -184.14M | -180.77M | -176.76M | -170.71M | -164.27M | -158.01M | -149.65M | -141.79M | -134.35M | -120.71M | -110.22M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |